Abstract
BACKGROUND: An unresolved issue in T regulatory (Treg) cell biology is the lack of consensus on phenotypic markers that accurately define the natural Treg (nTreg) population. OBJECTIVES: To examine nTreg frequency and functional capacity in healthy controls, and their frequency in asthmatic subjects using three different phenotypic strategies. We hypothesized that phenotypically different nTreg are quantitatively and functionally different. METHODS: 34 healthy, non-asthmatic and 17 asthmatic subjects were studied. Three nTreg phenotypes were defined: nTreg1 (CD4(+) CD25(+) Foxp3(+) ), nTreg2 (CD4(+) CD25(+) CD127(low) Foxp3(+) ), and nTreg3 (CD4(+) CD25(high) Foxp3(+) ). The flow cytometric determination of nTreg frequency in peripheral blood (PB) and bronchoalveolar lavage (BAL) was performed using fluorescently labelled antibodies. PB nTreg functional capacity was assessed using a CFSE-based suppression assay. RESULTS: There was a significantly lower frequency of peripheral blood nTreg3 compared to nTreg2 and nTreg1 (p
Original language | English |
---|---|
Journal | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology |
DOIs | |
Publication status | Published - 14 Jul 2015 |
Keywords
- BAL
- Foxp3
- T regulatory cell
- asthma
- flow cytometry
- peripheral blood
- suppression assay